Contact Us
Chengguan District, Lanzhou, Gansu, China
© 2025 Jeifer Pharmaceutical, All Right
Reserved.
Looking back, sodium metabisulfite did not always live in the highly regulated pharmaceutical landscape. Chemists produced salts like this well before the age of globally harmonized standards, but the advent of the BP, EP, and USP pharmacopeias carved a precise path. Each standard drove improvements in purity, accessibility, safety profiles, and physical characteristics. Over the last half-century, growing market demand in medicine and food conservation prompted improvements in synthetic routes, quality control, and traceability. Today’s product represents a blend of old-school inorganic chemistry and modern manufacturing priorities, rooted in those historical mandates for reproducibility and patient safety.
Sodium metabisulfite continues to serve as both a pharmaceutical excipient and a preservative. The powder or crystalline granules dissolve fast in water, making it practical for injectable solutions, oral medications, and active pharmaceutical ingredient (API) stabilization. I’ve seen its role extend into color preservation, antioxidation, and sulfonation reactions. Because pharmacopoeial grades enforce restrictions on heavy metals, microbial contamination, and insoluble residues, end-users like pharmaceutical companies and hospital pharmacies value its consistency. Compared to other preservatives or antioxidants, sodium metabisulfite remains readily available, cost-effective, and highly characterized.
This compound presents as a white to slightly yellow powder, with a strong odor typical of sulfur derivatives. It easily picks up water from the air, so manufacturers seal it tightly to prevent caking and decomposition. Its solubility in cold water exceeds 65g in 100mL, reflecting strong ionic dissociation. In solution, sodium metabisulfite forms bisulfite ions, which participate readily in redox reactions. A molar mass of about 190g/mol gives it the right proportion for many laboratory and industrial recipes. The pH of its aqueous solution ranges acidic, often landing between 3.5 to 5, supporting its action in fighting oxidative damage in sensitive preparations.
Suppliers document sodium metabisulfite along the lines set by BP, EP, and USP. Labels abroad consistent batch numbers, storage temperatures (well below 30°C, shielded from light and humidity), and certifications of heavy metals, arsenic content, sulfur dioxide percentage, and microbial load. The accompanying certificate of analysis details assay values, which fall within a narrow range for regulatory acceptance. Each lot must test negative for common contaminants like thiosulfate, chlorides, and iron. In my experience, pharmaceutical buyers screen for even minor deviations, so tight quality management sits at the center of this supply chain.
Manufacturing sodium metabisulfite on a pharmaceutical scale means reacting sulfur dioxide with sodium carbonate or sodium hydroxide, followed by dehydration of the resultant sodium bisulfite solution. The process takes place in closed reactors to limit operator exposure to harmful gases and ensure uniform chemical composition. Crystallization, filtration, and drying remove impurities, and modern plants often integrate continuous monitoring for pH, SO₂ levels, and cation/anion purity. Post-synthesis, the product undergoes sieving to achieve a reproducible particle size distribution, a step I have seen reduce clumping issues and speed up downstream blending. Efficient, monitored preparation brings the pharmaceutical grade up to par with the detailed pharmacopeial guidelines.
Sodium metabisulfite acts as a robust reducing agent; it decolorizes permanganate and reacts cleanly with aldehydes to form bisulfite addition compounds. In pharmaceutical manufacturing, this allows it to quench excess oxidants or neutralize certain residues. When exposed to heat or acids, the compound liberates sulfur dioxide, which highlights its protective power as a preservative but also signals a risk of gastric irritation with oral medicines. Its reactivity spans further, as it can break down into sodium sulfite and eventually into sulfate under sustained oxidation, all steps with implications for storage stability, environmental fate, and product shelf life. Chemists sometimes modify the salt’s particle size or flow properties by blending with anti-caking agents, though such modifications require new regulatory review for pharma use.
Shoppers run across sodium pyrosulfite, disodium disulfite, and E223 on European food labels, all pointing to the same chemical. The pharma world generally refers to the substance strictly as sodium metabisulfite, but food and water treatment sectors still adopt older language. Some suppliers list trade names to differentiate particle grades or proprietary blends, yet chemical structure remains the same. Understanding this patchwork of synonyms helps minimize confusion in procurement and global logistics.
Handling sodium metabisulfite, especially on a manufacturing floor, requires robust ventilation and strict limits on dust exposure. The powder can irritate eyes, skin, and airways, and inhalation in sensitive individuals triggers asthmatic symptoms. Pharmaceutical-grade suppliers follow workplace limits set by OSHA and ACGIH, calling for full personal protective equipment and automated transfer lines where possible. GMP guidelines require traceability from raw materials to final containers, so every batch has an audit trail from synthesis to shipping. Labelling follows GHS protocols, warning clearly about inhalation risks, contact hazards, and spill response. Proper storage—cool, dry, away from acids and moisture—prevents dangerous gas formation and keeps product potent until use.
The pharmaceutical industry leans on sodium metabisulfite in injectables such as epinephrine, antibiotics, and certain antineoplastic agents, using it to safeguard actives from oxidation during storage or transport. I’ve seen its applications in parenteral nutrition, where solution clarity and absence of color change can make or break product acceptability. Food processing uses the compound to prevent browning in dried fruits and to inhibit microbial spoilage, extending shelf life and lowering health risks. Water municipalities dose it to neutralize chlorine after disinfection, reducing risks of off-flavor or residual oxidants in drinking water. These roles build trust in the chemical when sourced at pharma grade, where tighter limits on byproducts and allergens matter more than in industrial versions.
Pharmaceutical R&D continues to explore new formulations where sodium metabisulfite serves as a stabilizer for more sensitive or high-value drug actives. Recent research has pushed into lyophilized (freeze-dried) vaccine preparations, where its ability to inhibit peroxide formation preserves vaccine potency under variable storage loads. Teams are also studying its performance in polymer-based drug delivery systems, measuring whether it slows down degradation of certain polymers used in capsule shells or depot injections. Analytical advances, such as high-throughput LC-MS, let manufacturers probe impurities at levels unheard of twenty years ago, supporting claims of safety and regulatory adherence even as products grow more complex.
Inhalation remains a leading concern for operators and end-users alike. Studies show sodium metabisulfite can provoke respiratory distress and, in rare cases, severe allergic reactions, especially in asthmatic patients or those with sulfite sensitivity. Animal toxicology places single-dose oral LD50 values above 2000mg/kg, marking it as low in acute toxicity, but chronic exposure data highlights cumulative risks if standards slip. Some clinical literature documents skin irritation from repeated handling or accidental contamination. Agencies like the FDA and EMA set clear limits for use in food and medicine, and every decade brings new studies trying to unpack sub-acute and long-term effects. Most toxicologists agree strict adherence to pharmaceutical grade specifications and careful risk communication sharply reduces public health risks.
Regulatory trends push chemical suppliers toward even cleaner processes with less environmental runoff, lower greenhouse emissions, and fewer trace contaminants. Synthetic biology and green chemistry approaches stand ready to replace petrochemical-based routes. One area of focus is developing protective packaging to shield sodium metabisulfite from humidity and heat during global shipping without plastic waste. Researchers are probing whether nano-formulations enhance reactivity or reduce allergenic risks in sensitive formulations. Data analytics and machine learning methods inch closer to predicting stability or failure across heaps of real-world handling and storage situations, promising better management of supply chain risk. If the industry keeps the lid tight on quality and safety, sodium metabisulfite should hold its hard-won position in pharmaceutical excipients, even as new materials arrive on the scene.
Mention sodium metabisulfite in most circles and you’ll usually get a shrug, unless you’re talking to someone who reads ingredient lists for fun. But behind that dry, powdery look hides a backbone of pharmacy work. In factories, hospital basements, and production labs, this compound supports more than a handful of processes that keep people safe.
In manufacturing, medicines travel a tough road. Exposed to air and moisture, drugs can change in ways few patients ever realize. Oxidation can turn costly, complex compounds into something useless, or worse, harmful. Manufacturers use sodium metabisulfite as an antioxidant to slow those unwanted reactions. It plays this role in injectables, tablets, and even in topical creams.
I once worked with a pharmacist who explained how an antihistamine solution held up better thanks to this additive. Without it, there would be color shifts or the liquid would take on a foul smell by the time it reached the end of its shelf life. Around the globe, the European Pharmacopoeia (EP), United States Pharmacopeia (USP), and British Pharmacopoeia (BP) set high purity standards to ensure sodium metabisulfite does the job without causing its own set of problems.
Keeping medicine sterile isn’t just about filters and gloves. During manufacturing, bacteria and fungi look for any chance to spoil a batch. Here is where sodium metabisulfite takes another shift—its antimicrobial touch helps hold the line until the final product gets sealed. In large-scale production, this role keeps costs from ballooning due to contamination or wasted product.
People don’t only find sodium metabisulfite in pill bottles. In hospitals, it lurks in dialysate fluids. Blood transfusions and dialysis both rely on components untouched by bacteria or dangerous oxidation. With the right dose, technicians prevent patient reactions while keeping the fluid usable. These aren’t minor details; for people with kidney failure, it can be a factor that quietly affects how safe treatment feels.
Its use in food—think dried fruit and white wine—gives another view on why control matters. Improper use causes reactions in people sensitive to sulfites. Pharmaceutical grade brings a tighter leash on impurities and consistent composition, lowering the chance for surprises.
Every tool in pharma has trade-offs. Sodium metabisulfite carries warnings about allergic reactions, especially for patients with asthma. In clinical settings, doctors and pharmacists track formulas to avoid giving high-risk groups medications preserved this way. Labeling laws in countries like the US and across Europe require listing sulfites above a set level to keep allergic patients in the loop.
There’s also continual effort to refine purification methods—getting rid of trace contaminants like heavy metals. Some companies seek alternatives for especially sensitive patient populations. That said, for now the cost-benefit tips in favor of sodium metabisulfite in many medical processes.
The steady push for safer compounds and more transparent labeling stands out in medicine. As pharmaceutical manufacturing becomes more global, sticking to EP, BP, and USP grade standards protects both companies and patients. It’s not the flashiest job in the drug cabinet, but few ingredients play a bigger background role in keeping modern healthcare safe.
In the world of pharmaceuticals, details matter. Sodium metabisulfite that carries BP, EP, and USP badges has to meet tight standards. These acronyms stand for the British, European, and United States Pharmacopoeia, the main guides that set purity and quality levels. For folks working in manufacturing, these standards are far from red tape—they define how safe and reliable medicines turn out.
BP, EP, and USP all agree on what matters. Sodium metabisulfite in pharma grade needs a minimum purity, usually between 97-100%. Each guide may use different words, but the rules on impurities stay close. I’ve seen labs pause production for specks of iron, traces of arsenic, or heavy metal residue above trace limits. The top limit for lead, for example, often sits under 2 parts per million, and sometimes even lower. Nobody wants any doubt when batches reach patients who rely on medicine to stay afloat.
There’s a temptation to glance at chemical specs and think it’s all paperwork. Yet I remember hearing from a quality control chemist who explained the stakes. Even tiny amounts of impurities can kick off reactions that spoil products or, worse, put lives at risk for those with allergies or immune-suppressed conditions. Sodium metabisulfite serves in pharmaceutical manufacturing as an antioxidant, which helps keep injectable drugs stable and effective. If the purity dips, degradation can happen much sooner. It only takes one incident to see trust unravel.
Day to day, labs use titration, spectrophotometry, and wet chemistry methods to check sodium metabisulfite. Color matters, so the sample should be white or nearly so. It should smell faintly of sulfur dioxide—not like rotting eggs, but sharp enough to notice. Iron sits at 0.001% max, chloride at around 0.02%, and the acidity or alkalinity falls within a narrow pH range. Years ago, I watched a technician catch a batch that looked fine but failed the pH test. That batch never left the warehouse.
Reputation gets built on transparency and honesty in records. Any company supplying sodium metabisulfite to drugmakers must prove each lot meets every requirement. Certificates of analysis track impurities, test results, and traceability. With global supply chains, even the best lab tech can’t check every bag, so solid documents keep corners from getting cut. Factories risk major recalls if anything slips, and patients suffer for it most.
Solid solutions start with regular, independent audits that take lab results seriously. Using digital batch records helps sort through mountains of data. I’ve noticed that training staff to question batches—even if it means slowing down—keeps standards high. Not all suppliers will make the cut, and that’s alright. Pharmaceutical companies relying on sodium metabisulfite need to keep lines open with suppliers and be quick to investigate anything off. Slow down, double-check, build a culture that values caution, and patients end up safer for it.
Sodium metabisulfite lands on ingredient lists in tablets, injectables, and vaccines. Pharma grade versions, labeled BP, EP, or USP, mean they meet the purity standards set by the British, European, or United States Pharmacopoeia. This level of purity matters a lot in medicine because impurities in excipients can trigger bad reactions or affect how the drug works.
In my time talking with pharmacists and folks in pharmaceutical manufacturing, the topic of ingredient safety comes up every week. Nobody wants to see a medication batch get tossed because an excipient fails a test. Sodium metabisulfite helps prevent oxidation, which can destroy drugs during storage or shelf-life testing. Pharma grade material stands up to scrutiny—manufacturers check it for heavy metals, allergens, and other impurities. Migrating away from industrial grade chemicals toward those with recognized pharmacopoeial status helps limit unknowns.
The FDA and EMA list sodium metabisulfite as a permitted pharmaceutical excipient. It passes safety reviews at permitted concentrations. Swapping in lower purity versions can carry a risk: uncontrolled residues or contaminants can sneak into finished products. In rare cases, sodium metabisulfite causes allergic reactions, especially in people with asthma—this is widely documented, dating back decades. Drug makers must label this excipient where required, and serious oversight goes into exposure limits.
A friend of mine manages quality control at a medium-sized medicine firm. His team runs dozens of purity checks every week. He once rejected a sizeable bulk shipment when lab analysis flagged excessive trace metals, even though the label read “pharma grade.” GMP rules mean strict verification of both paperwork and actual content. Genuine pharma grade sodium metabisulfite passes these purity thresholds and comes with detailed documentation—this paperwork makes batch release a smoother process and gives doctors, pharmacists, and patients better peace of mind.
Sodium metabisulfite preserves the potency of drugs sensitive to oxygen—adrenaline and vitamin preparations are good examples. It helps maintain their shelf life and, when used correctly, supports the doctor’s and pharmacist’s ability to give patients consistent treatment results. Without it, medications prone to oxidation would spoil too quickly or become less effective by the time they reach the pharmacy.
One real issue is the risk in individuals with sulfite sensitivity. Most reactions are mild, but rare severe cases can come up, mostly in injectable therapies. Doctors and pharmacists remain vigilant, asking questions about allergies if there’s any sign of risk. The best approach involves careful supplier selection, ongoing verification, full transparency about sources, and clear labeling down the supply chain. Better transparency about the grade and origin of sodium metabisulfite reassures not just regulators, but everyone involved—including patients.
Sodium metabisulfite, when genuinely BP, EP, or USP pharma grade, fits into pharmaceutical products safely. The key is not cutting corners—manufacturers stick to certified suppliers, and pharmacies trust documented provenance over price. Everyone in the chain, from factory workers mixing batches to pharmacists handing out pills, plays a role in making sure these standards mean something. Sitting as an active ingredient in many life-saving drugs, its safety depends on the diligence of real people—not just the promises written on a barrel.
Sodium metabisulfite shows up in drug ingredients lists more often than people realize. It acts as a preservative, keeps products from oxidizing, and sometimes even appears in simple tablet coatings. But one thing about this chemical stands out: it reacts pretty strongly with moisture and acids. So, paying attention to how it gets stored and moved around in a pharmacy or manufacturing setting isn’t just about ticking boxes; it can mean the difference between a safe work environment and one with some real hazards.
From years working behind pharmacy counters and touring manufacturing plants, a consistent lesson surfaces—never let sodium metabisulfite anywhere near water. This powder pulls moisture right out of the air. Even a tiny open bag sitting for twenty minutes in a humid storeroom ends up clumping, and worse, it starts to break down. Breakdowns release sulfur dioxide, which not only smells terrible but also creates health risks. Direct inhalation of these fumes can irritate the lungs and eyes, not just for factory workers but for anyone nearby. Moisture control needs attention every single day.
Smart storage starts with basics: sealed containers, dry rooms, and good airflow. Heavy-duty plastic drums with tight lids usually do the job well, but double-bagging in high-grade polyethylene can sprint that extra mile in damp climates. It’s tough to trust “ordinary” cardboard drums unless they have a proper lining, as humidity ruins them quickly. Even the best setup turns useless if containers get left open during weighing or transfer, so everyone involved has to respect those rules, not just the lab manager.
Direct sunlight shouldn’t hit those storage drums. A little sun speeds up decomposition, plus, it heats up the area, leading to higher humidity. A temperature-controlled storeroom, set around 20 to 25 degrees Celsius, keeps the product stable and limits nasty surprises. Placing sodium metabisulfite well away from acids matters, too, since accidental mixing gives off dangerous, choking fumes in seconds.
No one wants powdered chemicals on their skin or in their eyes. Gloves and goggles don’t slow down work; they keep people safe. I’ve seen more than one careless handler wind up with red eyes and persistent coughing just from a five-minute exposure. It doesn’t take a chemical engineer to see what’s wrong there. Respiratory masks are not overkill, especially for large batches or in rooms with low airflow.
One small spilled bag, poorly labeled, can get mistaken for plain table salt, and disaster isn’t far behind. Clear, permanent labeling saves time and lives. Regular training—no matter how simple the takeaway—makes sure no one gets comfortable cutting corners. An annual session, even half an hour, is money and time well spent, and it means fewer emergencies.
Across labs and factories, practical routines form the backbone of safety. Investing in quality storage, reliable labeling, and routine training costs far less than cleaning up after accidents. Sodium metabisulfite has its place, but only if everyone treats it with respect. Many companies now use digital tracking for chemicals, flagging anything out of place instantly. That shift towards accountability makes a difference that statistics alone can’t fully show—because behind every guideline, there’s a real person.
Sodium metabisulfite isn’t the catchiest name on a product label, but for folks working in pharmaceuticals, it means strict packaging standards come into play. I’ve visited more than one warehouse packed with pharmaceutical raw materials, and you spot a familiar scene: industrial sacks, rigid drums, and even smaller airtight plastic containers depending on the needed volume. The goal is always the same—keep moisture and contaminants out, keep the compound stable until it reaches production.
People sometimes overlook the impact humidity and air have on this salt. Sodium metabisulfite breaks down if it takes on water from the air. That's why triple-layer laminated or polyethylene bags, often sealed inside HDPE drums or steel containers, have become solid choices. A paper bag, even if it looks pretty tough, won’t keep the contents safe for long. There’s a difference between storing fertilizer and an excipient meant for medicines; nobody wants a pharmacy product spoiling before it ever gets inside a tablet or solution.
Working in supply chains has taught me: the best packaging loses its benefits if people don’t label it clearly. Details like batch numbers, packing dates, and expiry are more important for inventory managers than marketing teams. Regulators look for this information before shipments even cross borders. The pharmaceutical world demands traceability, with no room for mystery on a drum's label.
Doctoring up expiration dates doesn’t work—not with sodium metabisulfite, and certainly not in pharma. Left unopened in airtight packaging away from sunlight and heat, reputable manufacturers promise a shelf life of up to two years. Rooms need to stay cool and dry. Walk into a humid, hot storeroom, and the contents may not last more than eighteen months. You’ll see caking, suspicious smells, or maybe a slight yellowing. This means sulfites have started breaking down; that lot goes to the hazardous waste bin, not production.
Temperature control isn’t just a luxury for high-income countries either. My conversations with logistics managers in Southeast Asia and South America have underscored the need for warehouse upgrades, even if this means insulated containers or dehumidifiers. Upfront costs are much lower than the price of writing off an entire batch.
Pharmaceutical companies, especially those handling large volumes, know to return any packaging that looks punctured or moisture-ridden. One-time opening rules apply. Once you break a seal, smaller containers offer a back-up plan for on-demand use. This way, the rest of the batch doesn’t get exposed every time a tech wants to weigh out 500 grams.
Problems with shelf life often come down to gaps in supply chain training and infrastructure. Tighter protocols for receiving and inspecting shipments catch problems early. Encouraging suppliers to double-bag or vacuum seal products, instead of sticking to the bare minimum, keeps risk down. Making space for regular audits and temperature mapping of storerooms closes the loop. When teams treat packaging as an investment instead of an afterthought, wasted product drops and complaints shrink.
People looking to avoid headaches in pharma manufacturing know sodium metabisulfite demands both good packaging and good habits. It may seem like a simple powder, until it isn’t.
| Names | |
| Preferred IUPAC name | sodium oxidooxididosulfate |
| Other names |
Disodium metabisulfite Sodium pyrosulfite SMBS |
| Pronunciation | /ˈsəʊdiəm ˌmɛtəˈbaɪˌsʌlfaɪt biː piː iː piː juː ɛs piː ˈfɑːrmə ɡreɪd/ |
| Identifiers | |
| CAS Number | 7681-57-4 |
| 3D model (JSmol) | `smi: [Na+].[Na+].[O-]S(=O)(=O)S[O-]` |
| Beilstein Reference | 3566596 |
| ChEBI | CHEBI:38101 |
| ChEMBL | CHEMBL1351 |
| ChemSpider | 39754 |
| DrugBank | DB14526 |
| ECHA InfoCard | 22bb3a25-6c48-4f5a-bd98-0513f396b0d4 |
| EC Number | 231-673-0 |
| Gmelin Reference | 68257 |
| KEGG | C00788 |
| MeSH | D017960 |
| PubChem CID | 109439 |
| RTECS number | WC5600000 |
| UNII | UN1F5CQG9G |
| UN number | UN 3077 |
| CompTox Dashboard (EPA) | DTXSID6044616 |
| Properties | |
| Chemical formula | Na2S2O5 |
| Molar mass | 190.10 g/mol |
| Appearance | White or slightly yellowish crystalline powder |
| Odor | Slight odor of sulfur dioxide |
| Density | 1.48 g/cm³ |
| Solubility in water | Freely soluble in water |
| log P | -4.0 |
| Acidity (pKa) | 7 |
| Basicity (pKb) | 6.2 |
| Magnetic susceptibility (χ) | -51.0×10⁻⁶ cm³/mol |
| Dipole moment | 0 D |
| Thermochemistry | |
| Std molar entropy (S⦵298) | 143.3 J·K⁻¹·mol⁻¹ |
| Std enthalpy of formation (ΔfH⦵298) | -947 kJ/mol |
| Std enthalpy of combustion (ΔcH⦵298) | -941 kJ/mol |
| Pharmacology | |
| ATC code | A0160 |
| Hazards | |
| Main hazards | Harmful if swallowed, causes serious eye damage, may cause allergy or asthma symptoms or breathing difficulties if inhaled. |
| GHS labelling | GHS05, GHS07 |
| Pictograms | GHS05, GHS07 |
| Signal word | Warning |
| Hazard statements | Hazard statements: "H302 Harmful if swallowed. H318 Causes serious eye damage. H335 May cause respiratory irritation. |
| Precautionary statements | P264, P271, P280, P301+P312, P304+P340, P305+P351+P338, P330, P337+P313, P403+P235, P501 |
| NFPA 704 (fire diamond) | 2-0-1-W |
| Autoignition temperature | > 190°C |
| Lethal dose or concentration | LD50 (oral, rat): 1132 mg/kg |
| LD50 (median dose) | LD50 (oral, rat): 1,540 mg/kg |
| NIOSH | WS5600000 |
| PEL (Permissible) | 5 mg/m³ |
| REL (Recommended) | 0.7 mg/m3 |
| IDLH (Immediate danger) | 250 mg/m3 |
| Related compounds | |
| Related compounds |
Sodium bisulfite Sodium sulfite Sodium sulfate Potassium metabisulfite Sulfur dioxide |
Chengguan District, Lanzhou, Gansu, China
